TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 SEK)
Closing information | 2024/03 | 2023/03 | 2022/03 |
Turnover |
38,009
|
43,802
|
41,152 |
Financial expenses |
69
|
158
|
724 |
Earnings before taxes |
864
|
1,997
|
1,468 |
EBITDA |
588
|
2,155
|
1,509 |
Total assets |
71,190
|
56,098
|
45,224 |
Current assets |
71,190
|
56,098
|
45,224 |
Current liabilities |
30,991
|
18,274
|
10,864 |
Equity capital |
40,199
|
37,824
|
34,360 |
- share capital |
254
|
248
|
227 |
Employees (average) |
16
![]() |
16
|
18 |
Financial ratios
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Solvency |
56.5%
|
67.4%
|
76.0% |
Turnover per employee |
2,376
|
2,738
|
2,286 |
Profit as a percentage of turnover |
2.3%
|
4.6%
|
3.6% |
Return on assets (ROA) |
1.3%
|
3.8%
|
4.8% |
Current ratio |
229.7%
|
307.0%
|
416.3% |
Return on equity (ROE) |
2.1%
|
5.3%
|
4.3% |
Change turnover |
-5,793
|
2,650
|
-6,876 |
Change turnover % |
-13%
|
6%
|
-14% |
Chg. No. of employees |
0
|
-2
|
-1 |
Chg. No. of employees % |
0%
|
-11%
|
-5% |
Total value of public sale
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.